Accelerated Pharma (Accelerated Pharma) Cash And Cash Equivalents : $0.06 Mil (As of Mar. 2017)

View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Cash And Cash Equivalents?

Accelerated Pharma's quarterly cash and cash equivalents declined from Sep. 2016 ($0.12 Mil) to Dec. 2016 ($0.06 Mil) but then increased from Dec. 2016 ($0.06 Mil) to Mar. 2017 ($0.06 Mil).

Accelerated Pharma's annual cash and cash equivalents increased from Dec. 2014 ($0.50 Mil) to Dec. 2015 ($0.66 Mil) but then declined from Dec. 2015 ($0.66 Mil) to Dec. 2016 ($0.06 Mil).

Accelerated Pharma Cash And Cash Equivalents Historical Data

The historical data trend for Accelerated Pharma's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma Cash And Cash Equivalents Chart

Accelerated Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Cash And Cash Equivalents

0.50

0.66

0.06

Accelerated Pharma Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Cash And Cash Equivalents	Get a 7-Day Free Trial			-	0.01	0.12	0.06	0.06

Accelerated Pharma Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Accelerated Pharma (NAS:ACCP) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Accelerated Pharma Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerated Pharma (Accelerated Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines